Currently, the share price for Mono Pharmacare Ltd. is delayed. Login to view live prices.
Mono Pharmacare Ltd.
₹25.90
NSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 122.34 | +353.28% |
| Other Income | 0.10 | -56.52% |
| Total Income | 122.44 | +349.82% |
| Total Expenditure | 119.21 | +353.44% |
| EBIDT | 6.42 | +266.86% |
| Depreciation | 0.12 | +140.00% |
| Interest | 3.08 | +300.00% |
| Tax | 0.77 | +234.78% |
| Net Profit | 2.46 | +251.43% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 80.16 | +31.15% |
| Total Non-Current Assets | 0.95 | -35.81% |
| Fixed assets | 0.91 | +7.06% |
| Total assets | 81.11 | +29.57% |
| Total Current Liabilities | 35.82 | +14.81% |
| Total Non-Current Liabilities | 17.17 | -4.66% |
| Total Capital Plus Liabilities | 81.11 | +29.57% |
| Total Shareholder Funds | 28.11 | +110.09% |
| Total Debt to Equity | 1.47 | -51.49% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | -8.77 | -68.40% |
| Cash from Financing Activities | 8.32 | -71.90% |
| Cash from Investing Activities | 0.40 | -127.78% |
| Net Cash Flow | -0.06 | -114.29% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer